NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,182 | -47.1% | 5,522 | +36.0% | 0.00% | – |
| Q2 2023 | $168,533 | -32.1% | 4,061 | -1.6% | 0.00% | – |
| Q1 2023 | $248,198 | -17.9% | 4,127 | +0.1% | 0.00% | – |
| Q4 2022 | $302,276 | -3.7% | 4,121 | -0.1% | 0.00% | – |
| Q3 2022 | $314,000 | +11.0% | 4,127 | +1.0% | 0.00% | – |
| Q2 2022 | $283,000 | -32.8% | 4,086 | -19.6% | 0.00% | – |
| Q1 2022 | $421,000 | -20.1% | 5,080 | -27.5% | 0.00% | – |
| Q4 2021 | $527,000 | -22.5% | 7,011 | +19.9% | 0.00% | -100.0% |
| Q3 2021 | $680,000 | -71.7% | 5,849 | -46.1% | 0.00% | -50.0% |
| Q2 2021 | $2,405,000 | +77.8% | 10,843 | +5.9% | 0.00% | +100.0% |
| Q1 2021 | $1,353,000 | -24.4% | 10,241 | -1.0% | 0.00% | -50.0% |
| Q4 2020 | $1,790,000 | +56.3% | 10,349 | +0.6% | 0.00% | +100.0% |
| Q3 2020 | $1,145,000 | +54.1% | 10,291 | -17.8% | 0.00% | 0.0% |
| Q2 2020 | $743,000 | +7330.0% | 12,516 | +7771.7% | 0.00% | – |
| Q1 2020 | $10,000 | -73.0% | 159 | -64.3% | 0.00% | – |
| Q4 2019 | $37,000 | -96.2% | 445 | -96.5% | 0.00% | -100.0% |
| Q3 2019 | $963,000 | -27.4% | 12,886 | -38.6% | 0.00% | 0.0% |
| Q2 2019 | $1,326,000 | +563.0% | 20,976 | +405.4% | 0.00% | – |
| Q1 2019 | $200,000 | -31.0% | 4,150 | -52.1% | 0.00% | – |
| Q4 2018 | $290,000 | +64.8% | 8,670 | +158.0% | 0.00% | – |
| Q3 2018 | $176,000 | -22.8% | 3,361 | -53.8% | 0.00% | – |
| Q2 2018 | $228,000 | +70.1% | 7,280 | +17.8% | 0.00% | – |
| Q1 2018 | $134,000 | +24.1% | 6,180 | +14.9% | 0.00% | – |
| Q4 2017 | $108,000 | +1700.0% | 5,380 | +572.5% | 0.00% | – |
| Q3 2016 | $6,000 | -40.0% | 800 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -16.7% | 800 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | -45.5% | 800 | -20.0% | 0.00% | – |
| Q4 2015 | $22,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |